What is Definium Therapeutics, Inc. Common Shares's Market Cap?

Definium Therapeutics, Inc. Common Shares's Market Cap is $4.8B, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Enterprise Value?

Definium Therapeutics, Inc. Common Shares's Enterprise Value is $3.7B, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's EV / EBITDA?

Definium Therapeutics, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Net Income (TTM)?

Definium Therapeutics, Inc. Common Shares's Net Income (TTM) is -$353.8M, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's EBITDA?

Definium Therapeutics, Inc. Common Shares's EBITDA is -$227.5M, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM)?

Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM) is -2.63, based on as-reported figures from SEC (XBRL) filings.

What is Definium Therapeutics, Inc. Common Shares's Net Debt?

Definium Therapeutics, Inc. Common Shares's Net Debt is -$1.0B, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Definium Therapeutics, Inc. Common Shares

XNAS · usd

SIC 2833 · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

FIGI BBG001TCSL84

35.67▼ 0.33 (-0.92%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 36.00
Day's Range: 35.09 – 36.12
52-Week Range: 14.62 – 49.70
Volume: 1.8M
Avg Volume: 2.4M

Share Statistics

Shares Outstanding
Employees: 106
Exchange: XNAS
Listed: 2020-03-03

Share count as of July 30, 2026

Definium Therapeutics, Inc. Common Shares (DFTX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Definium Therapeutics, Inc. Common Shares (DFTX)

What is Definium Therapeutics, Inc. Common Shares's Market Cap?: Definium Therapeutics, Inc. Common Shares's Market Cap is $4.8B, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Enterprise Value?: Definium Therapeutics, Inc. Common Shares's Enterprise Value is $3.7B, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's EV / EBITDA?: Definium Therapeutics, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Net Income (TTM)?: Definium Therapeutics, Inc. Common Shares's Net Income (TTM) is -$353.8M, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's EBITDA?: Definium Therapeutics, Inc. Common Shares's EBITDA is -$227.5M, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM)?: Definium Therapeutics, Inc. Common Shares's Diluted EPS (TTM) is -2.63, based on as-reported figures from SEC (XBRL) filings.
What is Definium Therapeutics, Inc. Common Shares's Net Debt?: Definium Therapeutics, Inc. Common Shares's Net Debt is -$1.0B, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · DFTXAs-filed SEC (XBRL) data